With the new CanG, Germany has removed medical cannabis from the narcotics list. Doctors can now prescribe cannabis to patients without extensive bureaucratic hurdles, and at the same time, the cultivation of medical cannabis in Germany is permitted. What impact does this have on the market regarding prescription numbers for private and insured patients? How do patients benefit from this? What do doctors and pharmacies say about the new legislation?
Moderator
Speakers
- Leif Burmeister
- Christiane Neubaur
- Marcus Reussmann
- Nicole Perenyi